European Disease Progression Monitor: Edition 4

COVID-19 disease progression monitor

EU Disease-progression-review

Italy, Spain and France past COVID-19 peak

Germany and U.K. later peaks than EU

latest death rate in EU

EU5 past COVID-19 peak intensity

COVID-19 treatments and preventative therapies

disease progression monitor disclaimer

For more information, please visit lek.com/covid19 or fill out this form to get in touch.

Other editions in this series:
European Disease progression monitor: Edition III

Sign-up here to receive Disease Progression Monitor updates.

Sign-up

Related Insights

Digital

Executive Insights

Automation and Jobs: Why CEOs Must Prepare for Structural Change

March 11, 2020

In 2017, L.E.K. Consulting’s Executive Insights “Jobs for the Bots” reviewed the Office of National Statistics (ONS) data on the UK labour market,…

Biotech and Pharmaceuticals

Published Articles

5 Essential Factors For A Successful Biopharma Product Launch

October 23, 2019

Rapid changes in the biopharma industry are making it increasingly difficult to launch new products successfully.

Life Sciences & Pharma

Executive Insights

New Drug Discovery Paradigm: Advances in 3D Tissue Models and Applications

July 9, 2020

We discuss recent advances in the field of 3D tissue models and their potential to improve the drug discovery paradigm.

MedTech

Published Articles

Strategic Hospital Priorities in APAC – Emerging Themes and Implications for Medtechs

April 1, 2020

With the COVID-19 crisis putting pressure on our healthcare systems, some short-term priorities will have obviously changed.

Life Sciences & Pharma

COVID-19

COVID-19 and Clinical Trials: Accelerating the Adoption of eClinical Technology

April 2, 2020

Interruptions to trial timelines are occurring with increasing frequency as sponsors and investigator sites feel the effects of the COVID-19 outbreak.

Strategy

COVID-19

Global Situation Report Insights Edition 1

May 27, 2020

The L.E.K. Global Situation Report is a uniquely rich, current, and customisable collection of indicators that provide a powerful recovery planning aide.